Ani Pharmaceuticals (ANIP) Construction in Progress (2012 - 2013)
Ani Pharmaceuticals' (ANIP) quarterly Construction in Progress came in at $197948.0 in Q3 2013, up 12.29% quarter-over-quarter from $176276.0 in Q2 2013.
Ani Pharmaceuticals (ANIP) Construction in Progress (2012 - 2013) Analysis & Trends
Ani Pharmaceuticals has disclosed Construction in Progress across 2 years of filings, most recently posting $197948.0 for Q3 2013.
- Construction in Progress for Q3 2013 came in at $197948.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2013 was $197948.0 (changed N/A YoY), and the FY2012 annual result was $208069.0, changed N/A from the prior year.
- Construction in Progress came in at $197948.0 for Q3 2013 at Ani Pharmaceuticals, up from $176276.0 in the prior quarter.
- In the past five years, Construction in Progress ranged from a high of $208069.0 in Q4 2012 to a low of $176276.0 in Q2 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Ani Pharmaceuticals | 1.68 Bn | 1.37 Bn | 143.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | 197,948.00 |
| Jun 30, 2013 | 176,276.00 |
| Dec 31, 2012 | 208,069.00 |